In many clinical trials, temperature monitoring is key for safeguarding the stability of drug kits and ultimately safeguarding patient safety. Often temperature information must be collected manually from several sources to get a complete overview of the drug kit’s temperature profile and its stability status. This is a time-consuming and error-prone process.
In this webinar, attendees will learn how Berlinger’s SmartView seamlessly integrates with interactive response technology (IRT) systems to instantly generate complete temperature profiles and automatically alarms when temperature limits have been breached or the stability budget has been consumed. Through this solution, patient safety can be guaranteed to a higher degree, decisions can be made quicker and proof of compliance made easier.
Harald van Weeren, Segment Manager Clinical Trials, Berlinger & Co. AG
Harald van Weeren is Segment Manager Clinical Trials at Berlinger & Co. AG, a leading supplier of integrated soft- and hardware temperature monitoring solutions for pharma and med-tech industries. He has over ten years of experience in Product Management and Market Segment Management, bringing value to customers with high-tech innovative solutions. van Weeren has a PhD in physics from the University of Twente, Netherlands.Message Presenter
Who Should Attend?
- Clinical trial managers who are seeking to improve the efficiency of their clinical trials
- Quality managers who are seeking for ways to further safeguard quality standards
- Medical monitors who are seeking to further safeguard patient safety
- IRT suppliers who are seeking to find new USPs in their product portfolio and increase customer satisfaction
- Logistics providers who are seeking to increase customer satisfaction
The Swiss company Berlinger & Co. AG develops, produces and distributes innovative temperature monitoring solutions for pharmaceutical and medical technology products with the aim to further improve efficiency and increase patient safety. Since its inauguration in 1865, Berlinger is a family business which allows us to think far beyond quarterly results. We are fully committed to long term customer success, as we think in generations. Innovation and quality are key for us to deliver customers success. We invest a considerable part into R&D to stay innovative, as we did the last 155 years and are truly international, proudly partnering with leading pharmaceutical companies and key healthcare organisations, such as WHO or UNICEF, in over 170 countries.